CORRESP 1 filename1.htm kool20190528_corresp.htm

 

CESCA THERAPEUTICS INC.
2711 Citrus Road
Rancho Cordova, CA 95742

 

 

May 28, 2019

 

 

VIA EDGAR

 

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Timothy Buchmiller

 

 

Re:

Cesca Therapeutics Inc.

 

 

Registration Statement on Form S-3 (Registration No. 333-231526)

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant, Cesca Therapeutics Inc., hereby requests that the above-referenced Registration Statement be declared effective at 4:00 p.m., Eastern Time, on May 30, 2019, or as soon as practicable thereafter.

 

 

Very truly yours,

 

     
  CESCA THERAPEUTICS INC.  

 

 

 

 

 

 

 

 

 

By:

/s/ Chris Xu

 

 

 

Chris Xu,

 

 

 

Chief Executive Officer